Posts in tag

cardiovascular


An article published by a doctor’s publication doesn’t tell the full story, says researcher A recent article in the Australian Doctor website called “Profit over patients? Concerns about pharmacy CV checks” …

Debbie Rigby takes a look at the latest in research news Fall risk and anticoagulation for atrial fibrillation in the elderly Guidelines for managing atrial fibrillation recommend systemic anticoagulation for …

Ahead of RedFeb Heart Research Month, Discount Drug Stores is urging all Australians to make their heart health a priority The pharmacy chain is asking consumers to be proactive about checking …

Debbie Rigby takes a look at the latest in research news Off-Label Dosing of Non-Vitamin K Antagonist Oral Anticoagulants and Adverse Outcomes Evaluation Of patients in the ORBIT-AF II trial …

Women from low socioeconomic backgrounds are 25% more likely to suffer a heart attack than disadvantaged men, a major new study has found Researchers from The George Institute for Global …

Label warnings on the possible cardiovascular risk of ADHD medications are inconsistent and ambiguous, say experts  Product labelling warning of the cardiovascular risks of ADHD medication is inconsistent, say researchers …

Debbie Rigby rounds up the latest in research news Pharmacist comprehensive review of treatment compared with STOPP-START criteria to detect potentially inappropriate prescription in older complex patients A prospective multicentre …

What role should pharmacy play in travel medicine? It’s highly likely that as professional services like vaccinations are increasingly provided by pharmacists, they will also have a more significant role …

A new report shows how vascular diseases and risk factors such as smoking and obesity may significantly contribute to dementia “Dementia is a serious and growing health problem in Australia …

Debbie Rigby takes a look at the latest research news Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease In this large double-blind event-driven trial, ticagrelor (90 mg twice daily) was …

Smokers under the age of 50 are more than eight times as likely as non-smokers to have a major heart attack, new research shows. This makes them the most vulnerable …

Celecoxib is no more likely to cause cardiovascular events than ibuprofen or naproxen, the PRECISION trial has found Before this trial, the cardiovascular safety of celecoxib as compared with nonselective …